Exact Sciences
EXAS
$66.43
Share price
-2.62%
Change (1 day)
39.59%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Exact Sciences (EXAS) Fails to deliver data
Key failure to deliver metrics for Exact Sciences:
- Last SEC data release: 2023-07-31
- Last 15 days FTD volume: $0.36 M
- Last 3 months FTD volume: $3.85 M
- Last year FTD volume: $37.58 M
Failures to deliver for Exact Sciences (EXAS) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Exact Sciences (EXAS) - since 2013
Volume in USD (price x number of shares), data since 2013Exact Sciences (EXAS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $19.92 M | -53.86% |
| 2022 | $43.18 M | -13.64% |
| 2021 | $50.01 M | -29.41% |
| 2020 | $70.84 M | -66.29% |
| 2019 | $0.21 B | 88.7% |
| 2018 | $0.11 B | 89.93% |
| 2017 | $58.64 M | 84.58% |
| 2016 | $31.77 M | -74.24% |
| 2015 | $0.12 B | -14.01% |
| 2014 | $0.14 B | 2583.01% |
| 2013 | $5.34 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sanofi SNY | $8.99 M | $87.65 M | 🇫🇷 France |
 Veracyte VCYT | $2 M | $17.65 M | 🇺🇸 USA |
 Antares Pharma ATRS | N/A | $5.91 M | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.24 M | $2.3 M | 🇺🇸 USA |
 Biocept
BIOC | $3.88 M | $3.88 M | 🇺🇸 USA |